Growth Metrics

Novartis Ag (NVS) EBIT (QoQ) (2009 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 1,710.66%
Mar 31, 2023 16.85%
Dec 31, 2022 -27.59%
Sep 30, 2022 -91.95%
Jun 30, 2022 1,089.34%
Mar 31, 2022 2.07%
Dec 31, 2021 -12.27%
Sep 30, 2021 -92.12%
Jun 30, 2021 1,689.10%
Mar 31, 2021 -16.13%
Dec 31, 2020 -5.82%
Sep 30, 2020 -92.32%
Jun 30, 2020 11,524.44%
Mar 31, 2019 15.19%
Dec 31, 2018 -33.80%
Sep 30, 2018 -85.59%
Jun 30, 2018 507.33%
Mar 31, 2018 34.10%
Dec 31, 2017 -21.79%
Sep 30, 2017 -82.89%
Jun 30, 2017 564.72%
Mar 31, 2017 -95.45%
Dec 31, 2016 2,028.25%
Sep 30, 2016 -6.84%
Jun 30, 2016 109,826,489.60%
Mar 31, 2016 -100.00%
Dec 31, 2015 55,670,103,092,683.51%
Mar 31, 2015 -6.85%
Dec 31, 2014 -4.20%
Sep 30, 2012 -14.08%
Jun 30, 2012 15.43%
Mar 31, 2012 -56.00%
Dec 31, 2011 141.94%
Sep 30, 2011 -8.09%
Jun 30, 2011 -29.20%
Mar 31, 2011 70.13%
Dec 31, 2010 -28.37%
Sep 30, 2010 46.26%
Jun 30, 2010 -91.63%
Mar 31, 2010 -69.30%
Dec 31, 2009 334.21%
Sep 30, 2009 871.96%
Jun 30, 2009 -88.45%